12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Company News  |  Deals

AdProTech, PowderJect deal

PJP's PowderJect Vaccines Inc. subsidiary (Madison, Wis.) will evaluate AdProTech's Immudaptin complement-driven molecular...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >